• Overview
• 34 min
  1. An introduction to epilepsy

  • Prof. Steven Schachter
• Epidemiology
• 38 min
  2. Incidence, prevalence, and risk factors for epilepsy, and mortality

  • Dr. Dale Hesdorffer
• Diagnosis and Medical Management
• 29 min
  3. Classification system of seizures and epilepsy

  • Dr. Joseph Sirven
• 43 min
  4. Epilepsy in children

  • Dr. Elaine Wirrell
• 25 min
  5. Molecular imaging in epilepsy

  • Prof. Matthias Koepp
• 52 min
  6. Principles of electroencephalography

  • Prof. Donald Schomer
• 54 min
  7. Electroencephalography and epilepsy

  • Prof. Donald Schomer
• 39 min
  8. Pharmacological treatment

  • Prof. Dieter Schmidt
• 45 min
  9. Diagnosis and treatment for psychogenic nonepileptic seizures

  • Dr. W. Curt LaFrance, Jr.
• 41 min
  10. Status epilepticus

  • Prof. Daniel Lowenstein
• 47 min
  11. Anti-seizure drugs: discovery and development

  • Dr. Roger Porter
• Surgery and Brain Stimulation
• 46 min
  12. Epilepsy

  • Prof. Gregory D. Cascino
• 30 min
  13. Therapeutic devices for epilepsy

  • Dr. Robert Fisher
• Non-pharmacological Treatments
• 21 min
  14. Alternative therapies

  • Prof. Steven Schachter
• Psychosocial Aspects
• 37 min
  15. Epilepsy stigma and quality of life

  • Prof. Ann Jacoby
• Genetics and Neurobiology
• 57 min
  16. Genetic influences on human epilepsy

  • Prof. Russell J. Buono
• 68 min
  17. Epileptogenesis

  • Dr. Susan T. Herman
• 41 min
  18. Animal models of seizures and epilepsy

  • Dr. Wolfgang Löscher
• Global Burden of Epilepsy
• 32 min
  19. The global burden of epilepsy

  • Prof. Ley Sander
• Archived Lectures *These may not cover the latest advances in the field
• 48 min
  20. Epilepsy in children

  • Dr. Gregory L. Holmes

Printable Handouts

PDF

Navigable Slide Index

1. Introduction
2. Complementary and alternative therapies (CAM)
3. CAM in epilepsy
4. Therapies that fit into CAM
5. Outline
6. Scope of use of herbs by epilepsy patients
7. Regulatory aspects of herbs in U.S.
8. U.S. Regulation of Herbs
9. Standards set forth by the DSHEA
10. Quality control issues
11. Unmet medical needs in epilepsy
12. Epilepsy drug statistics (1)
13. Epilepsy drug statistics (2)
14. Why botanicals?
15. Botanical treatment for epilepsy
16. East Asian literature: herbs for epilepsy (1)
17. East Asian literature: herbs for epilepsy (2)
18. FDA guidance for botanical drug products
19. Chemicals in botanical drug products
20. Harvard epilepsy botanical program
21. Harvard epilepsy botanical program: goals
22. Harvard epilepsy botanical program: global team
23. Step 1: Identify
24. Step 2: Acquisition
25. Step 3: in vivo and in vitro models
26. Step 4: compound isolation and testing
27. Step 5: clinical trials
28. Extracts, mixtures and compounds
29. From tradition to bench to bedside
30. Alternative therapies: conclusions

Topics Covered

• Complementary and alternative therapies (CAM) in epilepsy
• Scope of use of herbs and regulatory aspects
• Standards set forth by the DSHEA
• Quality control issues
• Unmet medical needs
• Epilepsy drug statistics
• Why botanicals?
• East Asian literature of herbs
• FDA guidance
• Chemicals in botanical drug products
• Harvard epilepsy botanical program
• From tradition to bench to bedside

Links

Series:

• Epilepsy and Seizures

Categories:

• Clinical Practice
• Neuroscience

Therapeutic Areas:

• Neurology

Talk Citation

Publication History

• Published on May 3, 2011

Financial Disclosures

• Prof. Steven Schachter, Consultant: Cyberonics.